Showing results (1421-1430 of 3,525) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|February 25, 2022
Response to ALK-TKIs in a lung adenocarcinoma patient harboring dual DCTN1-ALK and ALK-CLIP4 rearrangementsFangfang Gao, Fangfang Gao, Huijuan Wu, et al.
Thoracic Cancer|April 30, 2019
Age- and gender-specific disease distribution and the diagnostic accuracy of CT for resected anterior mediastinal lesionsJu Gang Nam, Jin Mo Goo, Chang Min Park, et al.
Thoracic Cancer|April 25, 2019
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibodyXi Wang, Bo Zhang, Xuelian Chen, et al.
Thoracic Cancer|April 26, 2019
Safety and efficacy of thermal ablation for subpleural lung cancersFei Cao, Lin Xie, Han Qi, et al.
Thoracic Cancer|April 13, 2019
Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patientsLi Liao, Huajian Yu, Mengxi Ge, et al.
Thoracic Cancer|June 1, 2019
Prognostic value of quantitative measurement of EGFR mutation using peptide nucleic acid clamping in advanced EGFR mutant non-small cell lung cancer patientsInsu Kim, Jung Seop Eom, Eun Jung Jo, et al.
Thoracic Cancer|May 3, 2019
Ultralow dose computed tomography protocol for hook-wire localization of solitary pulmonary nodules prior to video-assisted thoracoscopic surgeryBo Liu, Jie Fang, Haipeng Jia, et al.
Thoracic Cancer|October 17, 2018
Body surface area as a novel risk factor for chylothorax complicating video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancerShuangjiang Li, Yan Wang, Kun Zhou, et al.
Thoracic Cancer|October 25, 2021
Heterogeneous radiological response to chemotherapy is associated with poor prognosis in advanced non-small-cell lung cancerWoo Kyung Ryu, Jung Soo Kim, Mi Hwa Park, et al.
Thoracic Cancer|October 27, 2021
Comparing survival and treatment response of patients with acquired T790M mutation second-line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A real-world studyChin-Chou Wang, Chien-Hao Lai, Yu-Ping Chang, et al.
Pageof 353